Big Pharma Split Corp. Big Pharma Split Corp.

Big Pharma Split Corp.

PRM

Rank in Stocks #27491
Big Pharma Split Corp, a closed-end equity investment fund, was established on... Big Pharma Split Corp, a closed-end equity investment fund, was established on September 15, 2017, and maintains its domicile in Canada. Overseen by Harvest Portfolios Group Inc., the fund concentrates its investments primarily within the pharmaceutical sector, targeting publicly traded companies across the United States.
Share Price
$11.33
Last synced: 2026-11-09
Market Cap
$14.88M
Change (1 day)
1.85%
Change (1 year)
26.37%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Financial Services
Operating Margin for Big Pharma Split Corp. (PRM)
Operating Margin as of November 2026 TTM: 232.85%
According to Big Pharma Split Corp.'s latest financial reports, its current operating margin (TTM) is 232.85%. At the end of 2025 the company had an operating margin of 346.00%.
Operating Margin history for Big Pharma Split Corp. from 2017 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 232.85% -32.70%
2025 346.00% 47,297.26%
2024 0.73% -101.63%
2023 -44.80% -155.92%
2022 80.12% -11.53%
2021 90.56% 951.80%
2020 8.61% -53.91%
2019 18.68% -89.85%
2018 184.05% 131.83%
2017 79.39% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
30.75% -99.87%
US
52.04% -99.78%
US
86.97% -99.63%
SE
7.84% -99.97%
US
66.24% -99.72%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Big Pharma Split Corp.'s operating margin

What is Big Pharma Split Corp.'s operating margin?

Big Pharma Split Corp.'s operating margin is 232.85%, as of Nov 2026.

What was Big Pharma Split Corp.'s operating margin in 2025?

In 2025, Big Pharma Split Corp.'s operating margin was 346.00%, compared with 0.73% in 2024.

How has Big Pharma Split Corp.'s operating margin changed since 2020?

From 2020 to 2025, Big Pharma Split Corp.'s operating margin was highest in 2025 (346.00%) and lowest in 2023 (-44.80%).

How does Big Pharma Split Corp.'s operating margin compare with similar companies?

Big Pharma Split Corp.'s operating margin (232.85%) is higher than that of all 5 similar companies listed above. The highest among them is Investor AB (publ), with 86.97%.